2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO34] Mini-Oral Session 34　Translational Research / Clinical Pharmacology 5（Basic science, Biomarker）
【E】

Sat. Feb 19, 2022 2:00 PM - 2:40 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Toshio Shimizu（Early Phase 1 Drug Development Service, Department of Experimental Therapeutics, National Cancer Center Hospital），Yoshihiko Segawa（Department of Medical Oncology, International Medical Center, Saitama Medical University）

[MO34-2] MiR-125b-5p regulate epithelial-mesenchymal transition and sorafenib resistance in Hepatocellular Carcinoma

○Akihiro Hirao1, Yasushi Sato1, Hironori Tanaka1, Takahiro Tanaka1, Tetsu Tomonari1, Tatsuya Taniguchi1, Koichi Okamoto1, Naoki Muguruma1, Kensei Nishida2, Tetsuji Takayama1 (1.Department of Gastroenterology and Oncology, Tokushima University, 2.Department of Pathophysiology, Tokushima University Graduate School of Biomedical Sciences)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password